近日，据中央纪委国家监委驻国务院国资委纪检监察组、辽宁省纪委监委消息，国药集团原党委委员、副总经理，上海现代制药股份有限公司原党委书记、董事长周斌涉嫌严重违纪违法，目前正接受中央纪委国家监委驻国务院国资委纪检监察组和辽宁省葫芦岛市监委纪律审查。
周斌在担任国药集团党委委员、副总经理期间，负责集团的战略规划、投资管理、资本运作等工作，对公司的业务发展起到了关键作用。然而，近年来，随着其职务的上升，他的行为也逐渐偏离了轨道。
此次周斌被审查调查，显示出我党对腐败问题的零容忍态度。无论职位高低，只要触犯法律，都将受到应有的惩罚。同时，这也再次提醒广大党员干部要时刻保持清醒头脑，严守党纪国法，切实做到清正廉洁。
据悉，此次审查调查将严格按照程序进行，公正公平地对待每一位涉案人员。我们将持续关注此事的进展，并及时发布最新情况。
英语如下：
News Title: “Former Senior Executives of Sinopharm Group Suspected of Serious Disciplinary and Legal Violations Under Scrutiny”
Keywords: Sinopharm Group, Zhou Bin, Review and Investigation
Content:
According to the Central Commission for Discipline Inspection (CCDI) and the National Supervisory Commission (NJC) of the State-owned Assets Supervision and Administration Commission (SASAC), Zhou Bin, former member of the Party Committee and vice president of Sinopharm Group, as well as former Communist Party Secretary and chairman of Shanghai Modern Pharmaceutical Co., Ltd., is suspected of serious disciplinary and legal violations.
During his tenure as a member of the Party Committee and vice president of Sinopharm Group, Zhou was responsible for the group’s strategic planning, investment management, and capital operations, playing a key role in the company’s business development. However, over the years, as his position rose, his behavior gradually deviated from the norm.
The investigation into Zhou highlights the CPC’s zero tolerance stance on corruption. Regardless of rank or status, anyone who violates the law will be punished accordingly. This also serves as a reminder to all party and government officials to remain vigilant, abide by party discipline and national laws, and uphold integrity and honesty.
It is reported that the review and investigation will be conducted according to strict procedures, treating every suspect fairly and impartially. We will continue to follow this case and release updates in a timely manner.
【来源】http://www.chinanews.com/gn/2024/01-31/10156181.shtml
Views: 1